Kurt Fernstrom
Examiner (ID: 5518, Phone: (571)272-4422 , Office: P/3711 )
Most Active Art Unit | 3711 |
Art Unit(s) | 3714, 3712, 3715, 3711 |
Total Applications | 2669 |
Issued Applications | 1756 |
Pending Applications | 157 |
Abandoned Applications | 755 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 14145705
[patent_doc_number] => 10253213
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-04-09
[patent_title] => Silk protein coatings
[patent_app_type] => utility
[patent_app_number] => 14/958775
[patent_app_country] => US
[patent_app_date] => 2015-12-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 24962
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14958775
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/958775 | Silk protein coatings | Dec 2, 2015 | Issued |
Array
(
[id] => 15225089
[patent_doc_number] => 10500249
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-12-10
[patent_title] => Compositions and methods for preventing or treating diseases, conditions, or processes characterized by aberrant fibroblast proliferation and extracellular matrix deposition
[patent_app_type] => utility
[patent_app_number] => 14/943752
[patent_app_country] => US
[patent_app_date] => 2015-11-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 26
[patent_figures_cnt] => 26
[patent_no_of_words] => 73398
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 214
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14943752
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/943752 | Compositions and methods for preventing or treating diseases, conditions, or processes characterized by aberrant fibroblast proliferation and extracellular matrix deposition | Nov 16, 2015 | Issued |
Array
(
[id] => 13622095
[patent_doc_number] => 20180362599
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-12-20
[patent_title] => MODIFICATIONS AND USES OF CONOTOXIN PEPTIDES
[patent_app_type] => utility
[patent_app_number] => 15/525024
[patent_app_country] => US
[patent_app_date] => 2015-11-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15316
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -35
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15525024
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/525024 | Modifications and uses of conotoxin peptides | Nov 5, 2015 | Issued |
Array
(
[id] => 10613846
[patent_doc_number] => 09333273
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-05-10
[patent_title] => 'Targeting constructs'
[patent_app_type] => utility
[patent_app_number] => 14/927865
[patent_app_country] => US
[patent_app_date] => 2015-10-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15108
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 70
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14927865
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/927865 | Targeting constructs | Oct 29, 2015 | Issued |
Array
(
[id] => 12260584
[patent_doc_number] => 20180079780
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-03-22
[patent_title] => 'NOVEL PEPTIDE COMPOUND, PRODUCTION METHOD THEREFOR, AND USE THEREOF'
[patent_app_type] => utility
[patent_app_number] => 15/521222
[patent_app_country] => US
[patent_app_date] => 2015-10-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 9314
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15521222
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/521222 | Peptide compound, production method therefor, and use thereof | Oct 22, 2015 | Issued |
Array
(
[id] => 11738308
[patent_doc_number] => 09702883
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-07-11
[patent_title] => 'Peptides, devices, and methods for the detection of anaplasma antibodies'
[patent_app_type] => utility
[patent_app_number] => 14/885443
[patent_app_country] => US
[patent_app_date] => 2015-10-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 51175
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 888
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14885443
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/885443 | Peptides, devices, and methods for the detection of anaplasma antibodies | Oct 15, 2015 | Issued |
Array
(
[id] => 10676634
[patent_doc_number] => 20160022780
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-01-28
[patent_title] => 'UROCORTIN 2 ANALOGS AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 14/878874
[patent_app_country] => US
[patent_app_date] => 2015-10-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12963
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14878874
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/878874 | UROCORTIN 2 ANALOGS AND USES THEREOF | Oct 7, 2015 | Abandoned |
Array
(
[id] => 10676625
[patent_doc_number] => 20160022770
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-01-28
[patent_title] => 'USE OF GLYCOMACROPEPTIDE TO IMPROVE WOMEN\'S HEALTH'
[patent_app_type] => utility
[patent_app_number] => 14/872641
[patent_app_country] => US
[patent_app_date] => 2015-10-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 22
[patent_no_of_words] => 21736
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14872641
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/872641 | USE OF GLYCOMACROPEPTIDE TO IMPROVE WOMEN'S HEALTH | Sep 30, 2015 | Abandoned |
Array
(
[id] => 10760536
[patent_doc_number] => 20160106689
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-04-21
[patent_title] => 'USE'
[patent_app_type] => utility
[patent_app_number] => 14/860970
[patent_app_country] => US
[patent_app_date] => 2015-09-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9803
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14860970
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/860970 | USE | Sep 21, 2015 | Abandoned |
Array
(
[id] => 12832015
[patent_doc_number] => 20180169177
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-06-21
[patent_title] => POLYPEPTIDE SPECIFICALLY BINDING TO CD34 MOLECULE AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 15/119418
[patent_app_country] => US
[patent_app_date] => 2015-09-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4591
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 51
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15119418
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/119418 | POLYPEPTIDE SPECIFICALLY BINDING TO CD34 MOLECULE AND USE THEREOF | Sep 21, 2015 | Abandoned |
Array
(
[id] => 10743262
[patent_doc_number] => 20160089413
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-03-31
[patent_title] => 'USE OF CELL-PERMEABLE PEPTIDE INHIBITORS OF THE JNK SIGNAL TRANSDUCTION PATHWAY FOR THE TREATMENT OF CHRONIC OR NON-CHRONIC INFLAMMATORY EYE DISEASES'
[patent_app_type] => utility
[patent_app_number] => 14/849374
[patent_app_country] => US
[patent_app_date] => 2015-09-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 21
[patent_no_of_words] => 26336
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14849374
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/849374 | USE OF CELL-PERMEABLE PEPTIDE INHIBITORS OF THE JNK SIGNAL TRANSDUCTION PATHWAY FOR THE TREATMENT OF CHRONIC OR NON-CHRONIC INFLAMMATORY EYE DISEASES | Sep 8, 2015 | Abandoned |
Array
(
[id] => 11210928
[patent_doc_number] => 09439943
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-09-13
[patent_title] => 'Use of melanocortins to treat insulin sensitivity'
[patent_app_type] => utility
[patent_app_number] => 14/844128
[patent_app_country] => US
[patent_app_date] => 2015-09-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 54271
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 54
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14844128
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/844128 | Use of melanocortins to treat insulin sensitivity | Sep 2, 2015 | Issued |
Array
(
[id] => 10797720
[patent_doc_number] => 20160143876
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-05-26
[patent_title] => 'MAINTENANCE THERAPY REGIME/REGIMEN FOR THE TREATMENT OF ACNE'
[patent_app_type] => utility
[patent_app_number] => 14/840968
[patent_app_country] => US
[patent_app_date] => 2015-08-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11751
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14840968
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/840968 | MAINTENANCE THERAPY REGIME/REGIMEN FOR THE TREATMENT OF ACNE | Aug 30, 2015 | Abandoned |
Array
(
[id] => 12126255
[patent_doc_number] => 20180009841
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-01-11
[patent_title] => 'METHOD FOR PREPARING NANOPRECIPITATES OF LOW MOLECULAR WEIGHT PEPTIDE OR PROTEIN'
[patent_app_type] => utility
[patent_app_number] => 15/506446
[patent_app_country] => US
[patent_app_date] => 2015-08-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 10638
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15506446
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/506446 | METHOD FOR PREPARING NANOPRECIPITATES OF LOW MOLECULAR WEIGHT PEPTIDE OR PROTEIN | Aug 25, 2015 | Abandoned |
Array
(
[id] => 11729303
[patent_doc_number] => 20170190744
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-07-06
[patent_title] => 'DALBAVANCIN COMPOSITIONS FOR TREATMENT OF BACTERIAL'
[patent_app_type] => utility
[patent_app_number] => 14/813914
[patent_app_country] => US
[patent_app_date] => 2015-07-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 41
[patent_figures_cnt] => 41
[patent_no_of_words] => 68311
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14813914
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/813914 | DALBAVANCIN COMPOSITIONS FOR TREATMENT OF BACTERIAL | Jul 29, 2015 | Abandoned |
Array
(
[id] => 11204017
[patent_doc_number] => 09433629
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-09-06
[patent_title] => 'Formulation for regeneration of bone, cartilage, teeth, and periodontium and treatment of tumors and cysts'
[patent_app_type] => utility
[patent_app_number] => 14/809417
[patent_app_country] => US
[patent_app_date] => 2015-07-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 25
[patent_figures_cnt] => 85
[patent_no_of_words] => 13981
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 37
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14809417
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/809417 | Formulation for regeneration of bone, cartilage, teeth, and periodontium and treatment of tumors and cysts | Jul 26, 2015 | Issued |
Array
(
[id] => 13289247
[patent_doc_number] => 10155799
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-12-18
[patent_title] => Chromatography process for purification of insulin and insulin analogs
[patent_app_type] => utility
[patent_app_number] => 15/327096
[patent_app_country] => US
[patent_app_date] => 2015-07-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 8377
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 305
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15327096
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/327096 | Chromatography process for purification of insulin and insulin analogs | Jul 15, 2015 | Issued |
Array
(
[id] => 11979324
[patent_doc_number] => 20170283478
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-10-05
[patent_title] => 'PROCESS FOR PREPARATION OF LIRAGLUTIDE'
[patent_app_type] => utility
[patent_app_number] => 15/325119
[patent_app_country] => US
[patent_app_date] => 2015-07-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6132
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15325119
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/325119 | PROCESS FOR PREPARATION OF LIRAGLUTIDE | Jul 12, 2015 | Abandoned |
Array
(
[id] => 10692414
[patent_doc_number] => 20160038560
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-02-11
[patent_title] => 'ANGIOTENSIN PEPTIDES IN TREATING MARFAN SYNDROME AND RELATED DISORDERS'
[patent_app_type] => utility
[patent_app_number] => 14/796366
[patent_app_country] => US
[patent_app_date] => 2015-07-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 22016
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14796366
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/796366 | ANGIOTENSIN PEPTIDES IN TREATING MARFAN SYNDROME AND RELATED DISORDERS | Jul 9, 2015 | Abandoned |
Array
(
[id] => 10694012
[patent_doc_number] => 20160040158
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-02-11
[patent_title] => 'PROTEIN SCREENING METHODS'
[patent_app_type] => utility
[patent_app_number] => 14/796480
[patent_app_country] => US
[patent_app_date] => 2015-07-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 37
[patent_figures_cnt] => 37
[patent_no_of_words] => 25746
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 16
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14796480
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/796480 | Protein screening methods | Jul 9, 2015 | Issued |